NewsEvents

Your Yourlocation: Home > Clinical efficacy and safety of tiotropium bromide(136310-93-5) combined with budesonide formoterol inhalation in the treatment of chronic obstructive pulmonary disease

The study of the efficacy and safety of budesonide formoterol inhalation combined with tiotropium bromide(136310-93-5) in the treatment of chronic obstructive pulmonary disease (COPD), and the study found that budesonide / formoterol combined with tiotropium inhalation treatment of chronic obstruction lung disease is conducive to control the clinical symptoms, improve lung function and quality of life, high safety. This article published on "China modern medicine application".

The aim of this study was to investigate the clinical efficacy and safety of budesonide formoterol inhalation combined with tiotropium bromide(136310-93-5) in the treatment of chronic obstructive pulmonary disease (COPD).

METHODS: Ninety patients with chronic obstructive pulmonary disease (COPD) were randomly divided into observation group and control group A and B with 30 patients in each group. Control group A received tiotropium, group B received budesonide /formoterol, and observation group received tiotropium bromide(136310-93-5) combined with budesonide / formoterol. The therapeutic effects of the three groups were observed.(FEV1), maximum expiratory flow velocity (PEF) and FEV1 were significantly higher in the observation group than those in the control group A and B (P <0.05). The observed expiratory volume (FEV1) (P <0.05) .Conclusion: The treatment group is better than the control group (P <0.05). Three groups of patients have no significant adverse reactions.

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved